Letter

Letter to GAO Requesting Review of FDA’s Assessments, Billings, and Collections of Tobacco User Fees


09.20.17

Excerpt: “Given the importance of user fees to FDA’s regulation of tobacco products and the length of time since the user fee final rule, the committee believes this is a reasonable time to conduct a financial review and evaluate the implementation of the new user fee rule at FDA.”

To read a copy of the letter, click here.

Letter